Home / Inspections / 645466

645466

Teva Pharmaceuticals USA, Inc — FEI 3003092769

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 1, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Parsippany, NJ (United States)

Facility

Other inspections at this facility

  • 1258587 (NAI Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219319 (VAI Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1160882 (NAI Thu Dec 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 703036 (VAI Thu Dec 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 600741 (VAI Fri Aug 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure
256721 CFR 211.198(a)Adverse Drug Experience
358521 CFR 211.110(a)Control procedures to monitor and validate performance
890821 CFR 314.81(b)(2)(i)Summary
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications